ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Bluesaint
|
102 |
23K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
102
|
23K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Bluesaint
|
102 |
23K |
4 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
102
|
23K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
743
|
181K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
4 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
743
|
181K
|
4
|
|
ASX - By Stock
|
EQR |
Re:
Ann: Investor Update / Webinar
|
|
Bluesaint
|
36 |
8.5K |
4 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
36
|
8.5K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
8 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
743
|
181K
|
8
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
4 |
1.4K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
4
|
1.4K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
58 |
16K |
13 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
58
|
16K
|
13
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
0 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
743
|
181K
|
0
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
2 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
743
|
181K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
0 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
743
|
181K
|
0
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
743
|
181K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
743
|
181K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
743
|
181K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
5 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
743
|
181K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
15 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
743
|
181K
|
15
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
2 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
743
|
181K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
5 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
743
|
181K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
743
|
181K
|
8
|
|
ASX - By Stock
|
EQR |
Re:
Ann: Investor Update NWR Sydney Resources Lunch 2024
|
|
Bluesaint
|
47 |
14K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
47
|
14K
|
0
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Bluesaint
|
326 |
100K |
3 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
326
|
100K
|
3
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Bluesaint
|
326 |
100K |
7 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
326
|
100K
|
7
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Bluesaint
|
326 |
100K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
326
|
100K
|
2
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Bluesaint
|
326 |
100K |
7 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
326
|
100K
|
7
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Suspension from Quotation
|
|
Bluesaint
|
12 |
5.1K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
12
|
5.1K
|
1
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Suspension from Quotation
|
|
Bluesaint
|
12 |
5.1K |
1 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
12
|
5.1K
|
1
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Suspension from Quotation
|
|
Bluesaint
|
12 |
5.1K |
0 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
12
|
5.1K
|
0
|
|
ASX - By Stock
|
SPQ |
Re:
Ann: Phase 2 Drilling Program commences at Bottletree
|
|
Bluesaint
|
188 |
48K |
3 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
188
|
48K
|
3
|
|
ASX - By Stock
|
SPQ |
Re:
Ann: Phase 2 Drilling Program commences at Bottletree
|
|
Bluesaint
|
188 |
48K |
1 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
188
|
48K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
4 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
743
|
181K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
743
|
181K
|
1
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Hydrocarbon Samples from Mukuyu-2 Discovery at Laboratory
|
|
Bluesaint
|
462 |
135K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
462
|
135K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Half Yearly Report and Accounts
|
|
Bluesaint
|
2 |
1.2K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
2
|
1.2K
|
1
|
|
ASX - By Stock
|
EQR |
Re:
Ann: Saloro XRT Sorting Performance Update
|
|
Bluesaint
|
83 |
25K |
0 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
83
|
25K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
115 |
31K |
6 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
115
|
31K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
115 |
31K |
3 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
115
|
31K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
115 |
31K |
4 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
115
|
31K
|
4
|
|
ASX - By Stock
|
EQR |
Re:
Ann: Saloro XRT Sorting Performance Update
|
|
Bluesaint
|
83 |
25K |
2 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
83
|
25K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
115 |
31K |
7 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
115
|
31K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
115 |
31K |
2 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
115
|
31K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
115 |
31K |
6 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
115
|
31K
|
6
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
743 |
181K |
0 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
743
|
181K
|
0
|
|
ASX - By Stock
|
SPQ |
Re:
Ann: Quarterly Activities Report
|
|
Bluesaint
|
158 |
43K |
0 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
158
|
43K
|
0
|
|
ASX - By Stock
|
ALC |
Re:
General Discussion / Social Media
|
|
Bluesaint
|
6.1K |
3.6M |
4 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
6.1K
|
3.6M
|
4
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Hydrocarbon Samples from Mukuyu-2 Discovery at Laboratory
|
|
Bluesaint
|
462 |
135K |
5 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
462
|
135K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Receipt of R&D Tax incentive payment
|
|
Bluesaint
|
34 |
9.5K |
5 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
34
|
9.5K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Receipt of R&D Tax incentive payment
|
|
Bluesaint
|
34 |
9.5K |
10 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
34
|
9.5K
|
10
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Bluesaint
|
161 |
39K |
1 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
161
|
39K
|
1
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Bluesaint
|
161 |
39K |
2 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
161
|
39K
|
2
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
Bluesaint
|
161 |
39K |
1 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
161
|
39K
|
1
|
|